Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL (ASPIRIN)
Comparative Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Sponsor: Northwestern University
A PHASE4 clinical study on Gestational Hypertension and Hypertensive Disorders of Pregnancy, this trial is actively recruiting participants. The trial is conducted by Northwestern University and has accumulated 8 data snapshots since 2024. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE4
-
Sep 2025 — Jan 2026 [monthly]
Recruiting PHASE4
-
Jul 2025 — Sep 2025 [monthly]
Recruiting PHASE4
-
Jun 2025 — Jul 2025 [monthly]
Recruiting PHASE4
-
Mar 2025 — Jun 2025 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Dec 2024 — Mar 2025 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Not Yet Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Northwestern University
- Ohio State University
- Patient-Centered Outcomes Research Institute
- Preeclampsia Foundation
For direct contact, visit the study record on ClinicalTrials.gov .